Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Bailey

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cancer Chemotherapy and Pharmacology|October 9, 2008
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignanciesSteven Attia, Sherry Morgan-Meadows, Kyle D Holen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical OncologyGregory A Masters, Lada Krilov, Howard H Bailey, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cancer Chemotherapy and Pharmacology|October 9, 2008
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignanciesSteven Attia, Sherry Morgan-Meadows, Kyle D Holen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical OncologyGregory A Masters, Lada Krilov, Howard H Bailey, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Pageof 6